Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct
Abstract
No abstract availableFunding Information
- Innovative Medicines Initiative (115557)
- Seventh Framework Programme
This publication has 6 references indexed in Scilit:
- The ADVANCE Code of Conduct for collaborative vaccine studiesVaccine, 2017
- The Vaccine Safety Datalink: successes and challenges monitoring vaccine safetyVaccine, 2014
- Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?Journal of Internal Medicine, 2014
- Guillain-Barré Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in EuropePLOS ONE, 2014
- Post-licensure rapid immunization safety monitoring program (PRISM) data characterizationVaccine, 2013
- Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in EuropeBMJ, 2011